Mesenchymal Cell News 10.29 July 24, 2018 | |
| |
TOP STORYInvestigators used Fas-deficient MRL/lpr and Caspase 3−/− mice to show that reduction of apoptotic body formation significantly impaired the self-renewal and osteo-/adipo-genic differentiation of bone marrow MSCs. Moreover, they used a parabiosis mouse model to reveal that apoptotic bodies participated in the circulation to regulate distant MSCs. [Cell Res] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROA photocontrolled upconversion-based substrate was designed and constructed for guiding multidirectional differentiation of MSCs. MSCs cultured on the upconversion substrate could be specifically induced to differentiate to adipocytes or osteoblasts by adjusting the near-infrared laser. [Angew Chem Int Ed Engl] Abstract BMSCs and miR-124a Ameliorated Diabetic Nephropathy via Inhibiting Notch Signaling Pathway Researchers found that bone marrow MSCs (BMSCs) were induced into islet-like cells and that miR-124a could promote the BMSCs to differentiate into islet-like cells. BMSCs in combination with miR-124a regulated islet cell-specific transcription factors, apoptosis-related genes, podocytes-related genes, as well as the activity of Notch signaling pathway. [J Cell Mol Med] Full Article Investigators focused on MSCs, recently recognized as bronchiolitis obliterans syndrome key effectors, and their primary aim was to identify their epigenetic determinants, such as histone modifications and non-coding RNA regulation, which could contribute to their differentiation in myofibroblasts. They identified a deregulated expression of histone deacetylases and methyltransferases, and a microRNA-epigenetic regulatory network. [Sci Rep] Full Article Mice lacking SnoN or expressing a mutant ski-related oncogene SnoN (SnoN) defective in binding to the Smads were protected from high fat diet-induced obesity and insulin resistance, and MSCs lacking a functional SnoN exhibited defective differentiation. SnoN repressed activin/Smad2 signaling and activin A expression, enabling expression of adipocyte-specific transcription factors and promoting adipogenic differentiation. [J Biol Chem] Full Article Scientists examined the effect of platelet-rich plasma (PRP) treatment on chondrogenic differentiation of adult human MSCs derived from infrapatellar fat pad-adipose stem cells and bone marrow. Chondrogenesis was inhibited with increasing PRP concentrations and duration of exposure, on the basis of histological, biochemical, and gene expression analyses. [Tissue Eng Part A] Abstract Investigators showed that non-differentiating and osteogenic cultivation conditions induced proliferation and showed increasing capacities of the glycolytic marker enzyme phosphofructokinase as well as the marker enzyme of the pentose phosphate pathway glucose-6-phosphate dehydrogenase. Adipogenic stimulation, which was accompanied by the absence of proliferation, reduced the glycolytic capacity and induced an increase in mitochondrial enzyme capacities. [Exp Cell Res] Abstract Addition of insulin-like growth factor binding protein 4 (IGFBP-4) inhibited bone marrow MSC (BMSC) proliferation and immunodepletion of IGFBP-4 increased the proliferation. IGFBP-4 promoted the growth of neurospheres derived from BMSCs, as manifested by the increases in the number and the size of the derived neurospheres. [Cell Biochem Funct] Abstract IN VIVOGenetic deletion of muscle segment homeobox 2 (MSX2) impaired human pluripotent stem cell differentiation into MSCs. When aided with a cocktail of soluble molecules, MSX2 ectopic expression induced hPSCs to form nearly homogeneous and fully functional MSCs. [Stem Cell Reports] Full Article Scientists used a combined treatment approach to modulate inflammation with adipose-derived MSCs while stimulating tendon regeneration with connective tissue growth factor (CTGF). The combined treatment was more effective than CTGF treatment alone, reducing the inflammatory IFNG and scar-associated COL3A1 gene expression and increasing CD146+ tendon stem/progenitor cells at the tendon surface and interior along the core suture tracks. [Sci Rep] Full Article Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSAdipose-Derived Mesenchymal Stem Cells: A New Tool for the Treatment of Renal Fibrosis The authors discuss the mechanisms involved in the treatment of renal fibrosis with adipose-derived MSCs (AMSCs) and summarize the potential hazards that may exist in cell therapy. [Stem Cells Dev] Abstract The Impact of Mesenchymal Stem Cells and their Secretome as a Treatment for Gliomas Investigators look with some detail into different studies using MSCs as a treatment for brain tumors and compare them, highlighting the main deviations and similarities among them. [Biochimie] Abstract Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSJoint Research Agreement for SB623 Targeting Dementia SanBio Company Limited announced it has concluded an agreement with Keio University School of Medicine on joint research for SB623 targeting dementia. SB623 consists of mesenchymal stem cells derived from adult bone marrow that undergo a genetic modification. [SanBio Co,Ltd.] Press Release UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments The governing board of the California Institute for Regenerative Medicine unanimously approved two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs. [UC San Diego Health] Press Release $50 Million To Provide Life-Saving Support To Cancer Patients The Turnbull Government will provide $50 million to support some of Australia’s sickest patients, battling the most aggressive and deadliest cancers, to access potentially life-saving medical treatment. The new national program – The Australian Genomic Cancer Medicine Program – will treat more than 5,000 patients nationally, from every state and territory. [Greg Hunt MP] Press Release | |
| |
POLICY NEWSNIH Delays Controversial Clinical Trials Policy for Some Studies Basic brain and behavioral researchers will get more than a year to comply with a new U.S. policy that will treat many of their studies as clinical trials. The announcement from the National Institutes of Health (NIH) appears to defuse, for now, a yearlong controversy over whether basic research on humans should follow the same rules as studies testing drugs. [ScienceInsider] Editorial University of Edinburgh Demands Retraction of Researcher’s Papers The University of Edinburgh has asked for the retraction of five papers by cell biologist and former faculty member Irina Stancheva following an internal investigation into scientific misconduct allegations, according to Times Higher Education. [The Scientist] Editorial
| |
EVENTSNEW EASL Basic School of Hepatology: Liver Cell Isolation and Characterization Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Stem Cell Biology (Washington University School of Medicine in St. Louis) PhD Student Positions – Regenerative Medicine (University Medical Center Utrecht) Senior Lecturer – Stromal Immunology (University of Aberdeen) Faculty Position – Cellular Physiology and Engineering (Mayo Clinic) Research Fellow – Stem Cell Biology and Engineering (New York Blood Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|